Beyond the IFA: Revisiting the ELISA as a More Sensitive, Objective, and Quantitative Evaluation of Spotted Fever Group <i>Rickettsia</i> Exposure

• Main Authors: Navatha Alugubelly, John V. Stokes, Claire E. Cross, Anne-Marie L. Ross, Anna E. Crawford, Gabrielle F. Fiihr, Andrea S. Varela-Stokes
• Format: Article
• Language: English
• Published: MDPI AG 2021-01-01
• Series: Pathogens
• Subjects: <i>Rickettsia parkeri</i>; Rickettsia amblyommatis; guinea pig; serology; tick-borne diseases; <i>Amblyomma</i>
• Online Access: https://www.mdpi.com/2076-0817/10/2/88

Based on limited serological studies, at least 10% of the US population has been exposed to spotted fever group <i>Rickettsia</i> (SFGR) species. The immunofluorescence antibody assay (IFA) has been the gold standard for the serodiagnosis of rickettsial infections such as spotted fever rickettsiosis (SFR). However, the IFA is semi-quantitative and subjective, requiring a high level of expertise to interpret it correctly. Here, we developed an enzyme-linked immunosorbent assay (ELISA) for the serodiagnosis of <i>Rickettsia parkeri</i> infection in the guinea pig. Our ELISA is an objective, quantitative, and high-throughput assay that shows greater sensitivity and resolution in observed titers than the IFA. We methodically optimized relevant parameters in sequence for optimal signal-to-noise ratio and low coefficient of variation% values. We used a guinea pig model as it is a part of our overall research efforts to understand the immunological and clinical response to SFGR species after tick transmission. Guinea pigs are a useful model to study SFR and show clinical signs of SFR, such as fever and eschars. We anticipate that this assay will be easily adapted to other hosts, including humans and other SFGR species.